The global alopecia market size is anticipated to reach USD 12.37 billion by 2025, according to a report published by Grand View Research, Inc. It is expected to expand at a CAGR of 5.5% during the forecast period. Technological advancements, growing disease prevalence, and environmental pollution, and increase in per-capita healthcare expenditures across the globe are anticipated to propel the growth.
Factors such as new product launches and technological advancements are also impacting the market dynamics. For instance, Hairmax Laser comb, Follinex Massager Comb, Lifemax Infrared Hair Brush, and hair growth renewing lasers are some of the products built on advanced technology. Also, the launch of new drugs is improving the treatment success rate and clinical outcomes.
Based on condition, the market is classified into alopecia areata, androgenetic alopecia, and others. Androgenetic alopecia segment led the market in 2018 with revenue of USD 7,242.7 million and is anticipated to grow at a lucrative CAGR over the forecast period. Factors responsible for high revenue of this segment include availability of various treatments such as topical treatments and oral treatments involving the use of minoxidil and finasteride and surgical treatments like hair transplantation and replacement. On the other hand, alopecia areata is anticipated to expand at the fastest CAGR of 6.3% over the forecast period.
On the basis of end use, the alopecia market is segmented into homecare settings and dermatology clinics. Dermatology clinics led the market in 2018 with a revenue of USD 4,696.4 million, due to the presence of a large number of dermatology clinics with new technologies and high adoption of prescription hair care products. Homecare settings segment is anticipated to register the fastest CAGR of 6.0% during the forecast period. Increasing availability of many new OTC medications and products along with increasing preference for convenience and ease of use are some of the factors responsible for this growth.
North America led the market in 2018 and is anticipated to expand at a lucrative rate over the forecast period. Factors attributed to this high revenue are high prevalence of autoimmune disorders such as Polycystic Ovary Syndrome (PCOS) and cancer. Moreover, presence of advanced healthcare infrastructure, high disposable income, and novel therapeutic options are anticipated to further fuel the growth. Asia Pacific is anticipated to grow at the fastest rate over the forecast period owing to increasing awareness regarding available treatment options for alopecia and increasing per capital healthcare expenditure in emerging countries such as China and India.
Some of the key companies operating in the alopecia market are Cipla Inc.; Sun Pharmaceutical Industries Ltd.; Johnson and Johnson AG; Merck & Co., Inc.; and Lexington International LLC, Cirrus Hair Centers, Vita-Cos-Med Klett-Loch GmbH; Transitions Hair Pty Ltd., Follica, Inc. and Capillus.
To request a sample copy or view summary of this report, click the link below:
Further key findings from the report suggest:
Androgenetic alopecia segment led the market in 2018 with revenue of USD 7,242.7 million, owing to increasing prevalence of androgenetic alopecia and growing awareness regarding the availability of treatments
Homecare settings is expected to witness the fastest CAGR of 6.0% over the forecast period owing to increasing preference for convenience and ease of use along with increasing availability of OTC medication
Asia Pacific is expected to witness the fastest CAGR owing to the high population base, increasing availability of treatment options, and growing per capita healthcare expenditure
Some of the key players in the alopecia market are Cipla Inc.; Sun Pharmaceutical Industries Ltd.; Johnson and Johnson AG; Merck & Co., Inc.; and Lexington International LLC, Cirrus Hair Centers, Vita-Cos-Med Klett-Loch GmbH; Transitions Hair Pty Ltd., Follica, Inc. and Capillus.
Grand View Research has segmented the global alopecia market on the basis of disease type, gender, sales channel, end use, and region:
Alopecia Disease Type Outlook (Revenue, USD Million, 2014 - 2025)
Alopecia End Use Outlook (Revenue, USD Million, 2014 - 2025)
Alopecia Sales Channel Outlook (Revenue, USD Million, 2014 - 2025)
Alopecia Gender Outlook (Revenue, USD Million, 2014 - 2025)
Alopecia Regional Outlook (Revenue, USD Million, 2014 - 2025)
Middle East & Africa
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."